JAK2 and acute lymphoblastic leukemia: In our case, the patient was an allo-HSCT candidate from the outset (initial diagnosis: Ph-like B-ALL) and remained a candidate after revision to MLN-eo-TK with PCM1::JAK2 rearrangement.